Cargando…

Death by TNF: a road to inflammation

Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only d...

Descripción completa

Detalles Bibliográficos
Autores principales: van Loo, Geert, Bertrand, Mathieu J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665039/
https://www.ncbi.nlm.nih.gov/pubmed/36380021
http://dx.doi.org/10.1038/s41577-022-00792-3
_version_ 1784831210769350656
author van Loo, Geert
Bertrand, Mathieu J. M.
author_facet van Loo, Geert
Bertrand, Mathieu J. M.
author_sort van Loo, Geert
collection PubMed
description Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only directly by inducing inflammatory gene expression but also indirectly by inducing cell death, instigating inflammatory immune reactions and disease development. Hence, inhibitors of cell death are being considered as a new therapy for TNF-dependent inflammatory diseases.
format Online
Article
Text
id pubmed-9665039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96650392022-11-16 Death by TNF: a road to inflammation van Loo, Geert Bertrand, Mathieu J. M. Nat Rev Immunol Review Article Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only directly by inducing inflammatory gene expression but also indirectly by inducing cell death, instigating inflammatory immune reactions and disease development. Hence, inhibitors of cell death are being considered as a new therapy for TNF-dependent inflammatory diseases. Nature Publishing Group UK 2022-11-15 2023 /pmc/articles/PMC9665039/ /pubmed/36380021 http://dx.doi.org/10.1038/s41577-022-00792-3 Text en © Springer Nature Limited 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
van Loo, Geert
Bertrand, Mathieu J. M.
Death by TNF: a road to inflammation
title Death by TNF: a road to inflammation
title_full Death by TNF: a road to inflammation
title_fullStr Death by TNF: a road to inflammation
title_full_unstemmed Death by TNF: a road to inflammation
title_short Death by TNF: a road to inflammation
title_sort death by tnf: a road to inflammation
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665039/
https://www.ncbi.nlm.nih.gov/pubmed/36380021
http://dx.doi.org/10.1038/s41577-022-00792-3
work_keys_str_mv AT vanloogeert deathbytnfaroadtoinflammation
AT bertrandmathieujm deathbytnfaroadtoinflammation